The ‘Year Of UHC’ – Interview With Swiss Global Health Amb. Nora Kronig Romero 07/02/2019 Health Policy Watch Universal health coverage, access to medicines, and noncommunicable diseases are priorities for Switzerland in global health policy. Amb. Nora Kronig Romero is the head of the International Affairs Division and Vice Director General of the Federal Office of Public Health, as well as Swiss Ambassador for Global Health. She sat down with Health Policy Watch while in Geneva last week for the meeting of the World Health Organization Executive Board, which Switzerland attended as an observer to the governing board comprised of 34 WHO member states. Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> Board Debates Medicines Access; WHO Asserts Mandate On IP, Trade Issues 30/01/2019 Catherine Saez Shortages, faulty supply chains, unbearable prices, weak health systems - the issue of access to medicines is multifaceted and gave way to a long list of interventions yesterday at the World Health Organization. Challenged on its mandate to address intellectual property and trade issues, WHO Director General Tedros Adhanom Gheyebresus (Dr Tedros) confirmed that WHO’s mandate includes work with partners on those issues. Discussions also included fair pricing and transparency, for which Italy called for a resolution at the next World Health Assembly. Continue reading -> Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> DNDi, MMV Make 400 Compounds Available To Boost Pandemic Disease Research 29/01/2019 William New The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) today announced the launch of the "Pandemic Response Box", which offers researchers free access to 400 compounds that could lead to development of new treatments for pandemic diseases. In return, researchers "will be expected to share data resulting from research on the molecules from the box in the public domain within 2 years of its generation." Continue reading -> Top Global Health Policy Issues – What To Watch In 2019 23/01/2019 David Branigan When historians look back, will this year mark a turning point in global health? Certainly some of the big issues on the agenda in 2019 might suggest that we are at a crossroads. We can expect to see an intensification of the push for universal health coverage (UHC), culminating with a first-ever high-level United Nations meeting, and a shift away from disease-specific interventions towards more integrated approaches. Health Policy Watch spoke with a range of leading global health policy experts from the World Health Organization (WHO), NGOs, industry and foundations to get their take on the top issues, and here is what they said to watch for in 2019 in five priority areas. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Enter The African Medicines Agency, Continent’s First Super-Regulator? 03/07/2017 Tatum Anderson An African medicines agency, the continent’s first super-regulator, could be approved as soon as next year. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> Board Debates Medicines Access; WHO Asserts Mandate On IP, Trade Issues 30/01/2019 Catherine Saez Shortages, faulty supply chains, unbearable prices, weak health systems - the issue of access to medicines is multifaceted and gave way to a long list of interventions yesterday at the World Health Organization. Challenged on its mandate to address intellectual property and trade issues, WHO Director General Tedros Adhanom Gheyebresus (Dr Tedros) confirmed that WHO’s mandate includes work with partners on those issues. Discussions also included fair pricing and transparency, for which Italy called for a resolution at the next World Health Assembly. Continue reading -> Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> DNDi, MMV Make 400 Compounds Available To Boost Pandemic Disease Research 29/01/2019 William New The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) today announced the launch of the "Pandemic Response Box", which offers researchers free access to 400 compounds that could lead to development of new treatments for pandemic diseases. In return, researchers "will be expected to share data resulting from research on the molecules from the box in the public domain within 2 years of its generation." Continue reading -> Top Global Health Policy Issues – What To Watch In 2019 23/01/2019 David Branigan When historians look back, will this year mark a turning point in global health? Certainly some of the big issues on the agenda in 2019 might suggest that we are at a crossroads. We can expect to see an intensification of the push for universal health coverage (UHC), culminating with a first-ever high-level United Nations meeting, and a shift away from disease-specific interventions towards more integrated approaches. Health Policy Watch spoke with a range of leading global health policy experts from the World Health Organization (WHO), NGOs, industry and foundations to get their take on the top issues, and here is what they said to watch for in 2019 in five priority areas. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Enter The African Medicines Agency, Continent’s First Super-Regulator? 03/07/2017 Tatum Anderson An African medicines agency, the continent’s first super-regulator, could be approved as soon as next year. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Board Debates Medicines Access; WHO Asserts Mandate On IP, Trade Issues 30/01/2019 Catherine Saez Shortages, faulty supply chains, unbearable prices, weak health systems - the issue of access to medicines is multifaceted and gave way to a long list of interventions yesterday at the World Health Organization. Challenged on its mandate to address intellectual property and trade issues, WHO Director General Tedros Adhanom Gheyebresus (Dr Tedros) confirmed that WHO’s mandate includes work with partners on those issues. Discussions also included fair pricing and transparency, for which Italy called for a resolution at the next World Health Assembly. Continue reading -> Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> DNDi, MMV Make 400 Compounds Available To Boost Pandemic Disease Research 29/01/2019 William New The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) today announced the launch of the "Pandemic Response Box", which offers researchers free access to 400 compounds that could lead to development of new treatments for pandemic diseases. In return, researchers "will be expected to share data resulting from research on the molecules from the box in the public domain within 2 years of its generation." Continue reading -> Top Global Health Policy Issues – What To Watch In 2019 23/01/2019 David Branigan When historians look back, will this year mark a turning point in global health? Certainly some of the big issues on the agenda in 2019 might suggest that we are at a crossroads. We can expect to see an intensification of the push for universal health coverage (UHC), culminating with a first-ever high-level United Nations meeting, and a shift away from disease-specific interventions towards more integrated approaches. Health Policy Watch spoke with a range of leading global health policy experts from the World Health Organization (WHO), NGOs, industry and foundations to get their take on the top issues, and here is what they said to watch for in 2019 in five priority areas. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Enter The African Medicines Agency, Continent’s First Super-Regulator? 03/07/2017 Tatum Anderson An African medicines agency, the continent’s first super-regulator, could be approved as soon as next year. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> DNDi, MMV Make 400 Compounds Available To Boost Pandemic Disease Research 29/01/2019 William New The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) today announced the launch of the "Pandemic Response Box", which offers researchers free access to 400 compounds that could lead to development of new treatments for pandemic diseases. In return, researchers "will be expected to share data resulting from research on the molecules from the box in the public domain within 2 years of its generation." Continue reading -> Top Global Health Policy Issues – What To Watch In 2019 23/01/2019 David Branigan When historians look back, will this year mark a turning point in global health? Certainly some of the big issues on the agenda in 2019 might suggest that we are at a crossroads. We can expect to see an intensification of the push for universal health coverage (UHC), culminating with a first-ever high-level United Nations meeting, and a shift away from disease-specific interventions towards more integrated approaches. Health Policy Watch spoke with a range of leading global health policy experts from the World Health Organization (WHO), NGOs, industry and foundations to get their take on the top issues, and here is what they said to watch for in 2019 in five priority areas. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Enter The African Medicines Agency, Continent’s First Super-Regulator? 03/07/2017 Tatum Anderson An African medicines agency, the continent’s first super-regulator, could be approved as soon as next year. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
DNDi, MMV Make 400 Compounds Available To Boost Pandemic Disease Research 29/01/2019 William New The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) today announced the launch of the "Pandemic Response Box", which offers researchers free access to 400 compounds that could lead to development of new treatments for pandemic diseases. In return, researchers "will be expected to share data resulting from research on the molecules from the box in the public domain within 2 years of its generation." Continue reading -> Top Global Health Policy Issues – What To Watch In 2019 23/01/2019 David Branigan When historians look back, will this year mark a turning point in global health? Certainly some of the big issues on the agenda in 2019 might suggest that we are at a crossroads. We can expect to see an intensification of the push for universal health coverage (UHC), culminating with a first-ever high-level United Nations meeting, and a shift away from disease-specific interventions towards more integrated approaches. Health Policy Watch spoke with a range of leading global health policy experts from the World Health Organization (WHO), NGOs, industry and foundations to get their take on the top issues, and here is what they said to watch for in 2019 in five priority areas. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Enter The African Medicines Agency, Continent’s First Super-Regulator? 03/07/2017 Tatum Anderson An African medicines agency, the continent’s first super-regulator, could be approved as soon as next year. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Top Global Health Policy Issues – What To Watch In 2019 23/01/2019 David Branigan When historians look back, will this year mark a turning point in global health? Certainly some of the big issues on the agenda in 2019 might suggest that we are at a crossroads. We can expect to see an intensification of the push for universal health coverage (UHC), culminating with a first-ever high-level United Nations meeting, and a shift away from disease-specific interventions towards more integrated approaches. Health Policy Watch spoke with a range of leading global health policy experts from the World Health Organization (WHO), NGOs, industry and foundations to get their take on the top issues, and here is what they said to watch for in 2019 in five priority areas. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Enter The African Medicines Agency, Continent’s First Super-Regulator? 03/07/2017 Tatum Anderson An African medicines agency, the continent’s first super-regulator, could be approved as soon as next year. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Enter The African Medicines Agency, Continent’s First Super-Regulator? 03/07/2017 Tatum Anderson An African medicines agency, the continent’s first super-regulator, could be approved as soon as next year. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Enter The African Medicines Agency, Continent’s First Super-Regulator? 03/07/2017 Tatum Anderson An African medicines agency, the continent’s first super-regulator, could be approved as soon as next year. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Enter The African Medicines Agency, Continent’s First Super-Regulator? 03/07/2017 Tatum Anderson An African medicines agency, the continent’s first super-regulator, could be approved as soon as next year. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Enter The African Medicines Agency, Continent’s First Super-Regulator? 03/07/2017 Tatum Anderson An African medicines agency, the continent’s first super-regulator, could be approved as soon as next year. Continue reading -> Posts navigation Newer posts